Following recent launch of UNIK Biotherapeutics (August 2025), we were delighted to learn about our nomination for Bionow’s Project of the Year Award 2025, which recognised our innovative work on payload research for ADC development. Our innovative research offers payload technologies with a greater tumour penetration, biodistribution and bystander effect to ensure more effective tumour eradication whilst reducing toxicity to normal tissues.